- ASSOCIATE PROFESSOR | Ophthalmology
- Hospital Affiliations
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Beth Israel
- Private Practice 646-820-2074646-820-2074
Rudrani Banik, MD, is Associate Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai and a member of the Ophthalmology Faculty Practice at New York Eye and Ear Infirmary of Mount Sinai. She is a Board-certified Ophthalmologist specializing in Neuro-Ophthalmology and Comprehensive Ophthalmology. She manages the entire spectrum of diseases affecting vision which arise from the nervous system including: optic neuritis, optic neuropathy (abnormality of optic nerve), optic disc edema (swelling of the optic nerve), ocular myasthenia gravis, brain tumors or stroke affecting vision, idiopathic intracranial hypertension or pseudotumor cerebri, unexplained visual loss, headaches (migraines), double vision, blepharospasm, and hemifacial spasm. She is fully trained in the use of Botulinum toxin (Botox) for facial spasms as well as cosmetic indications. She also performs cataract surgery, pterygium surgery and adult strabismus.
Dr. Banik is a graduate of the Brown University’s School of Medicine in Providence, RI and graduated with a B.A with Honors and M.D. She completed her residency training in Ophthalmology at the University of California, Irvine. She went on to pursue fellowship training in Neuro-Ophthalmology at the prestigious Wilmer Eye Institute at Johns Hopkins University. She served on the full-time faculty of the Albert Einstein College of Medicine/Montefiore Medical Center for over 3 years. Subsequently she served as Residency Program Director for Ophthalmology at Bronx-Lebanon Hospital Center for two years prior to joining the Faculty Practice at New York Eye and Ear Infirmary of Mount Sinai.
Dr. Banik is currently the Associate Director of the Neuro-Ophthalmology Service at New York Eye & Ear Infirmary of Mount Sinai and is the Director of the Fellowship program in Neuro-Ophthalmology. Dr. Banik's academic position combines her clinical activities with teaching and research. She is heavily involved in the supervision of residents and fellows. Her dedication to teaching future generations of ophthalmologists has won her the Attending of the Year Resident Teaching Award in 2005, 2010 and 2014. She is currently the principal investigator for several clinical trials in Neuro-Ophthalmology in idiopathic intracranial hypertension, non-arteritic anterior ischemic optic neuropathy, Leber Hereditary Optic Neuropathy and neuromyelitis optica. She has authored numerous articles in the field and has presented at national as well as international meetings. She has served as a reviewer for medical journals.
Dr. Banik is a fellow of the American Academy of Ophthalmology (AAO) as well as the North American Neuro-Ophthalmology Society (NANOS). She serves on numerous committees, including the American Board of Ophthalmology Exam Development Committee, NANOS AAO Committee, NANOS Patient Information Committee, NANOS Abstract Committee, NYEE's Ophthalmology PC Advisory Board, and ResidentCurriculum Committee and the Residency Selection Committee. Dr. Banik also specializes in Cataract Evaluation and Cataract Surgery.
MD, Brown University School of Medicine
Universtiy of California
Mount Sinai Medical Center (GME)
Fellowship, Neuro Ophthalmology
John Hopkins University School of Medicine
Bengali, English, French, SpanishDownload the CV
A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered by Single or Multi-Dose Intravitreal Injection(s) to Subjects with Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
The purpose of this research is to evaluate vision loss because there was not enough blood flow to the nerve tissue in the eye. This is sometimes called a stroke of the optic nerve. The medical term for this disease is Nonarteritic Anterior Ischemic Optic Neuropathy (...
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Banik did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.